Related Experiment Videos
Basic features of biofilms--why are they difficult therapeutic targets?
1Department of Orofacial Sciences, Division of Periodontology at the University of California San Francisco, 94143-0650, USA. garmit@itsa.ucsf.edu
Annals of the Royal Australasian College of Dental Surgeons
|February 17, 2006
Summary
This review explains how bacterial biofilms form in human infections and why they resist antimicrobial drugs. Biofilm bacteria survive through complex gene regulation and defense mechanisms, making infections difficult to treat.
Area of Science:
- Microbiology
- Infectious Diseases
- Biochemistry
Background:
- Bacterial biofilms are structured microbial communities often found on surfaces.
- Biofilms play a significant role in persistent and chronic human infections.
- These microbial communities exhibit enhanced resistance to antimicrobial treatments.
Purpose of the Study:
- To review the fundamental characteristics of biofilms in human infections.
- To summarize the mechanisms underlying biofilm resistance to antimicrobial agents.
Main Methods:
- Literature review of studies on bacterial biofilm formation and antimicrobial resistance.
- Analysis of gene regulation and community dynamics within biofilms.
- Identification of key factors contributing to drug resistance in biofilm environments.
Main Results:
- Biofilm formation involves bacterial adherence, growth, matrix synthesis, and community development.
- Transition to biofilms involves significant gene upregulation related to adherence.
- Established biofilms display complex gene regulation promoting bacterial survival.
- Mechanisms of antimicrobial resistance include drug neutralization, poor penetration, metabolic dormancy, and pre-existing resistance.
Conclusions:
- Bacterial biofilms present unique challenges in treating human infections due to inherent antimicrobial resistance.
- Understanding biofilm formation and resistance mechanisms is crucial for developing effective therapeutic strategies.
- Further research into biofilm-specific vulnerabilities is warranted to combat persistent infections.